A benefit–risk assessment model for statins using multicriteria decision analysis based on a discrete choice experiment in Korean patients

PURPOSE: The benefit–risk balance for drugs can alter post approval owing to additional data on efficacy or adverse events. This study developed a quantitative benefit–risk assessment (BRA) model for statins using multicriteria decision analysis with discrete choice experiments and compared a recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Byun, Ji-Hye, Kwon, Sun-Hong, Ha, Ji-Hye, Lee, Eui-Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912313/
https://www.ncbi.nlm.nih.gov/pubmed/27358567
http://dx.doi.org/10.2147/TCRM.S100438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912313/
https://www.ncbi.nlm.nih.gov/pubmed/27358567
http://dx.doi.org/10.2147/TCRM.S100438

Ejemplares similares